Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000902219-06-000831
Filing Date
2006-02-14
Accepted
2006-02-14 11:03:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 SEC FILING sec_filing.htm SC 13G/A 17908
  Complete submission text file 0000902219-06-000831.txt   20063
Mailing Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081
Business Address 4848 LOOP CENTRAL DRIVE SUITE 700 HOUSTON TX 77081 7137968822
ENCYSIVE PHARMACEUTICALS INC (Subject) CIK: 0000887023 (see all company filings)

EIN.: 133532643 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-44359 | Film No.: 06608509
SIC: 2834 Pharmaceutical Preparations

Mailing Address 75 STATE STREET BOSTON MA 02109
Business Address 75 STATE STREET BOSTON MA 02109 6179515000
WELLINGTON MANAGEMENT CO LLP (Filed by) CIK: 0000902219 (see all company filings)

EIN.: 042683227 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A
SIC: 0000